Betulinic acid in the treatment of breast cancer: Application and mechanism progress

Fitoterapia. 2023 Sep:169:105617. doi: 10.1016/j.fitote.2023.105617. Epub 2023 Jul 20.

Abstract

Betulinic acid (BA) is a pentacyclic triterpene compound, which can be obtained by separation, chemical synthesis and biotransformation. BA has excellent biological activities, especially its role in the treatment of breast cancer deserves attention. Its mechanisms mainly include inducing mitochondrial oxidative stress, regulating specific protein (Sp) transcription factors, inhibiting breast cancer metastasis, inhibiting glucose metabolism and NF-κB pathway. In addition, BA can also increase the sensitivity of breast cancer cells to other chemotherapy drugs such as paclitaxel and reduce its toxic side effects. This article reviews the application and possible mechanism of BA in the treatment of breast cancer.

Keywords: Betulinic acid; Breast cancer; Mechanism.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Betulinic Acid
  • Breast Neoplasms* / drug therapy
  • Female
  • Humans
  • Molecular Structure
  • Pentacyclic Triterpenes / pharmacology
  • Triterpenes* / chemistry
  • Triterpenes* / pharmacology

Substances

  • Pentacyclic Triterpenes
  • Betulinic Acid
  • Triterpenes